HEADER SIGNALING PROTEIN 28-NOV-17 6F3D TITLE IRAK4 IN COMPLEX WITH INHIBITOR CAVEAT 6F3D THR B 222 HAS WRONG CHIRALITY AT ATOM CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE RESIDUES NAMES TPO & SEP ARE THE PHOSPHORYLATED COMPND 8 FORM OF THR AND SER, RESPECTIVELY. THE PROTEIN HAS BEEN COMPND 9 PHOSPHORYLATED DURING PROTEIN EXPRESSION/PRODUCTION. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, INHIBITOR, CANCER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,S.L.DEGORCE,G.R.ROBB,A.D.FERGUSON REVDAT 1 23-MAY-18 6F3D 0 JRNL AUTH S.L.DEGORCE,R.ANJUM,K.S.DILLMAN,L.DREW,S.D.GROOMBRIDGE, JRNL AUTH 2 C.T.HALSALL,E.M.LENZ,N.A.LINDSAY,M.F.MAYO,J.H.PINK,G.R.ROBB, JRNL AUTH 3 J.S.SCOTT,S.STOKES,Y.XUE JRNL TITL OPTIMIZATION OF PERMEABILITY IN A SERIES OF PYRROLOTRIAZINE JRNL TITL 2 INHIBITORS OF IRAK4. JRNL REF BIOORG. MED. CHEM. V. 26 913 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29398441 JRNL DOI 10.1016/J.BMC.2018.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 PACIOREK REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 31225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1531 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.46 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.21 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2839 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2233 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2678 REMARK 3 BIN R VALUE (WORKING SET) : 0.2218 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.67 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 161 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4454 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.88 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.55360 REMARK 3 B22 (A**2) : -11.92360 REMARK 3 B33 (A**2) : 11.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.336 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.283 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.206 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.284 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.208 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4598 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6208 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1652 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 132 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 642 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4598 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 592 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5202 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.47 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 27.2803 35.0995 16.6977 REMARK 3 T TENSOR REMARK 3 T11: -0.1927 T22: -0.0394 REMARK 3 T33: -0.1748 T12: 0.0206 REMARK 3 T13: -0.0275 T23: -0.0396 REMARK 3 L TENSOR REMARK 3 L11: 2.7131 L22: 1.4341 REMARK 3 L33: 2.9141 L12: -0.0583 REMARK 3 L13: 0.7705 L23: -0.3017 REMARK 3 S TENSOR REMARK 3 S11: 0.1788 S12: 0.1184 S13: 0.2826 REMARK 3 S21: 0.0475 S22: -0.1422 S23: -0.2532 REMARK 3 S31: 0.0280 S32: 0.2926 S33: -0.0366 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -11.7572 28.2333 14.4204 REMARK 3 T TENSOR REMARK 3 T11: -0.0927 T22: -0.0120 REMARK 3 T33: -0.1568 T12: -0.0082 REMARK 3 T13: 0.0534 T23: -0.0129 REMARK 3 L TENSOR REMARK 3 L11: 1.6232 L22: 2.3821 REMARK 3 L33: 1.8479 L12: 0.4566 REMARK 3 L13: 0.1603 L23: 0.8204 REMARK 3 S TENSOR REMARK 3 S11: 0.1008 S12: -0.2934 S13: 0.0955 REMARK 3 S21: 0.1126 S22: -0.1721 S23: 0.2773 REMARK 3 S31: -0.0802 S32: -0.2196 S33: 0.0713 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6F3D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007193. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31282 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 94.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.52200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES PH 7.5, 0.02% REMARK 280 OCTYLGLUCOSIDE, 10% GLYCEROL, 0.3 M NACL, 1 MM TCEP, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.28400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.63900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.29900 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.28400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.63900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 71.29900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.28400 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.63900 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 71.29900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.28400 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.63900 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.29900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 THR A 342 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR B 222 N - CA - C ANGL. DEV. = 35.9 DEGREES REMARK 500 THR B 223 N - CA - CB ANGL. DEV. = 23.4 DEGREES REMARK 500 GLU B 224 N - CA - C ANGL. DEV. = -39.5 DEGREES REMARK 500 GLU B 225 N - CA - CB ANGL. DEV. = 24.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 207 -27.58 65.24 REMARK 500 ASP A 256 85.74 -69.05 REMARK 500 ASP A 257 150.09 126.74 REMARK 500 ARG A 310 -6.56 80.84 REMARK 500 ASP A 311 48.59 -143.35 REMARK 500 ASP A 329 90.52 60.13 REMARK 500 GLU A 406 25.14 43.37 REMARK 500 ASP B 181 107.17 -57.05 REMARK 500 ASN B 206 -104.00 59.14 REMARK 500 THR B 223 31.62 100.62 REMARK 500 GLU B 224 139.45 169.66 REMARK 500 GLU B 225 -43.29 105.18 REMARK 500 ARG B 310 -5.29 80.28 REMARK 500 ASP B 311 48.53 -144.76 REMARK 500 ASP B 329 91.48 59.72 REMARK 500 GLU B 406 25.48 42.90 REMARK 500 LYS B 417 30.99 -80.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJT B 502 DBREF 6F3D A 164 458 UNP Q9NWZ3 IRAK4_HUMAN 40 334 DBREF 6F3D B 164 458 UNP Q9NWZ3 IRAK4_HUMAN 40 334 SEQRES 1 A 295 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 2 A 295 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 3 A 295 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 4 A 295 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 5 A 295 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 6 A 295 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 7 A 295 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 8 A 295 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 9 A 295 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 10 A 295 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 11 A 295 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 12 A 295 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 13 A 295 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 14 A 295 ALA ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEQRES 15 A 295 SEP ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 16 A 295 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 17 A 295 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 18 A 295 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 19 A 295 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 20 A 295 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 21 A 295 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 22 A 295 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 23 A 295 VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 1 B 295 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 2 B 295 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 3 B 295 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 4 B 295 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 5 B 295 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 6 B 295 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 7 B 295 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 8 B 295 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 9 B 295 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 10 B 295 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 11 B 295 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 12 B 295 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 13 B 295 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 14 B 295 ALA ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEQRES 15 B 295 SEP ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 16 B 295 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 17 B 295 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 18 B 295 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 19 B 295 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 20 B 295 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 21 B 295 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 22 B 295 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 23 B 295 VAL GLN GLN LEU LEU GLN GLU MET THR MODRES 6F3D TPO A 345 THR MODIFIED RESIDUE MODRES 6F3D SEP A 346 SER MODIFIED RESIDUE MODRES 6F3D TPO B 345 THR MODIFIED RESIDUE MODRES 6F3D SEP B 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET SO4 A 501 5 HET CJT A 502 28 HET SO4 B 501 5 HET CJT B 502 28 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM SO4 SULFATE ION HETNAM CJT 4-[4-[[4-(DIMETHYLAMINO)CYCLOHEXYL]AMINO]-7~{H}- HETNAM 2 CJT PYRROLO[2,3-D]PYRIMIDIN-5-YL]CYCLOHEXANE-1-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 CJT 2(C21 H32 N6 O) FORMUL 7 HOH *113(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 LYS A 227 CYS A 240 1 14 HELIX 4 AA4 SER A 269 SER A 275 1 7 HELIX 5 AA5 CYS A 276 THR A 280 5 5 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 THR A 351 MET A 355 5 5 HELIX 9 AA9 ALA A 356 ARG A 361 1 6 HELIX 10 AB1 THR A 365 GLY A 383 1 19 HELIX 11 AB2 LEU A 395 LEU A 397 5 3 HELIX 12 AB3 ASP A 398 ASP A 405 1 8 HELIX 13 AB4 THR A 409 ILE A 414 1 6 HELIX 14 AB5 ASP A 422 LEU A 437 1 16 HELIX 15 AB6 ASP A 446 MET A 457 1 12 HELIX 16 AB7 SER B 169 THR B 177 1 9 HELIX 17 AB8 PRO B 184 GLY B 188 5 5 HELIX 18 AB9 GLU B 225 CYS B 240 1 16 HELIX 19 AC1 SER B 269 SER B 275 1 7 HELIX 20 AC2 CYS B 276 THR B 280 5 5 HELIX 21 AC3 SER B 284 ASN B 305 1 22 HELIX 22 AC4 LYS B 313 ALA B 315 5 3 HELIX 23 AC5 THR B 351 MET B 355 5 5 HELIX 24 AC6 ALA B 356 ARG B 361 1 6 HELIX 25 AC7 THR B 365 GLY B 383 1 19 HELIX 26 AC8 LEU B 395 LEU B 397 5 3 HELIX 27 AC9 ASP B 398 ASP B 405 1 8 HELIX 28 AD1 THR B 409 ILE B 414 1 6 HELIX 29 AD2 ASP B 422 LEU B 437 1 16 HELIX 30 AD3 ASP B 446 MET B 457 1 12 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N GLY A 250 SHEET 4 AA1 6 THR A 208 LEU A 215 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 GLY A 198 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLY A 195 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 6 HIS B 166 SER B 167 0 SHEET 2 AA3 6 LEU B 248 ASP B 254 1 O LEU B 249 N HIS B 166 SHEET 3 AA3 6 ASP B 257 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA3 6 THR B 208 LEU B 215 -1 N LEU B 215 O LEU B 258 SHEET 5 AA3 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA3 6 LYS B 191 GLY B 195 -1 N MET B 192 O VAL B 200 SHEET 1 AA4 2 HIS B 307 ILE B 308 0 SHEET 2 AA4 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA5 2 ILE B 317 LEU B 319 0 SHEET 2 AA5 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SEP A 346 1555 1555 1.35 LINK C SEP A 346 N ARG A 347 1555 1555 1.36 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.36 CISPEP 1 GLU A 392 PRO A 393 0 2.44 CISPEP 2 GLU B 392 PRO B 393 0 2.14 SITE 1 AC1 3 THR A 365 LYS A 367 LYS A 441 SITE 1 AC2 10 MET A 192 ALA A 211 LYS A 213 GLU A 233 SITE 2 AC2 10 TYR A 262 VAL A 263 TYR A 264 MET A 265 SITE 3 AC2 10 ASP A 272 LEU A 318 SITE 1 AC3 4 GLY B 350 THR B 351 THR B 352 HOH B 632 SITE 1 AC4 11 MET B 192 ALA B 211 LYS B 213 GLU B 233 SITE 2 AC4 11 TYR B 262 VAL B 263 MET B 265 ASP B 272 SITE 3 AC4 11 LEU B 318 HOH B 637 HOH B 642 CRYST1 86.568 125.278 142.598 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011552 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007982 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007013 0.00000